Skip to main content
. Author manuscript; available in PMC: 2014 Mar 3.
Published in final edited form as: Gynecol Oncol. 2012 May 15;126(3):351–356. doi: 10.1016/j.ygyno.2012.05.008

TABLE 5.

Comparison of patients < 19 years old and ≥ 19 years old

Patients < 19 Years (n=6) Women ≥ 19 Years (n=5)
Histology Embryonal (Botryoid variant) (5) Embryonal (Botryoid variant) (3)
Embryonal, variant unknown (1) Embryonal, variant unknown (1)
Undifferentiated (1)
Tumor stage IB1 (2) IB1 (2)
IB2 (2) IB2 (2)
IIA (1) Unknown (1)
Unknown (1)
Primary treatment Cone biopsy (4) Cone biopsy (2)
Polypectomy (1) TAH and BSO (2)
Chemotherapy (1) Chemotherapy (1)
Adjuvant treatment Chemotherapy (5) Chemoradiation (2)
TAH (1) None (2)
Cone biopsy (1)
Status at last follow-up No evidence of disease (4) Dead of other cause (2)
Alive with disease (1) No evidence of disease (1)
Dead of disease (1)* Alive with disease (1)
Unknown (1)

TAH, total abdominal hysterectomy; BSO, bilateral salpingo-oophorectomy.

*

Patient was < 19 years of age at diagnosis. Patient had a recurrence at >19 years of age.